Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.

Findings highlight the importance of infection prevention measures and personalized heart failure care.

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

The program provides subspecialty residents with the background and experience that will prepare them to care for children ... areas of immunology, infection control and hospital epidemiology enables ...